Although more studies are needed, our findings for the first time demonstrated that RhoA/ROCK2 signaling pathway plays a critical role in acrolein‐induced synaptic damage and cognitive dysfunction, suggesting inhibition of ROCK2 should benefit to the early AD. The gene discussed is ROCK2; the disease is Alzheimer disease.